Following the discovery of capsules found to be empty, Aurobindo Pharma USA has initiated a recall of the epilepsy treatment gabapentin, the company announced Nov. 21.

The company is voluntarily recalling lot GESB14011-A of 100-count bottles of 300 mg gabapentin, which have an expiration date of December 2015. The product also is used to manage postherpetic neuralgia (pain after shingles).

The Food and Drug Administration noted that the empty capsules could result in missed doses, potentially resulting in no effect, short-term efficacy reduction, short-term withdrawal effect, or status epilepticus that could be life threatening.

gtwachtman@frontlinemedcom.com

Ads

You May Also Like

Asymptomatic pancreatic cysts rarely became malignant

FROM CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Only 1% of adults with asymptomatic neoplastic pancreatic cysts ...

Counsel cryolipolysis patients about paradoxical adipose hyperplasia

AT THE ASDS ANNUAL MEETING SAN DIEGO (FRONTLINE MEDICAL NEWS) – Clinicians who perform ...

AHA: Childhood adversity strongly linked to poorer health outcomes

FROM CIRCULATION Research suggests an association between adverse childhood events and poorer cardiometabolic health ...